Overcast 41°
Tag:

Advisory Committee on Immunization Practices

News
PA Woman Hospitalized In NJ With Rare J&J Vaccine Related Blood Clot PA Woman Hospitalized In NJ With Rare J&J Vaccine Related Blood Clot
PA Woman Hospitalized In NJ With Rare J&J Vaccine Related Blood Clot One of the six women who developed clots as a result of the Johnson & Johnson COVID-19 vaccine is a Pennsylvania woman. The vaccine's use was temporarily halted nationwide after six women between the ages of 18 and 48 experienced blood clots. The New Jersey Health Department confirms that the woman they treated for the rare vaccine side effect is a resident of Pennsylvania who was hospitalized in New Jersey. The woman’s name will not be made public, but details about her have, she is 26, from an area bordering New Jersey and is gym instructor, according to a statement from the pharmac…

SHARE

by Jillian Pikora
News
CDC, FDA Call For Pause On Johnson & Johnson Vaccine CDC, FDA Call For Pause On Johnson & Johnson Vaccine
CDC, FDA Call For Pause On Johnson & Johnson Vaccine The US Centers for Disease Control and Prevention and the US Food and Drug Administration are calling for a pause on the use of Johnson & Johnson's COVID-19 vaccine due to six cases of "rare and severe" blood clot cases reported. All six cases occurred among women between 18 and 48, and symptoms occurred 6 to 13 days after vaccination, FDA officials said in a joint statement. More than 6.8 million doses of the one-dose vaccine had been administered in the U.S. All Pennsylvania teachers and administrators were given the J&J vaccine. Out of the 200,000 offered the vaccine a…

SHARE

by Cecilia Levine